Polaryx Therapeutics, Inc.
PLYXNasdaqCIK 2075320HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | period not labelled2025-03-31 | period not labelled2025-06-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|
| Research and development | $k | 4,716Research and development, period not labelled, three months to 2025-03-31$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | 476Research and development, period not labelled, three months to 2025-06-30$476.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 679Research and development, Q1 FY2026, three months to 2026-03-31$679.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | 719Research and development, Q2 FY2026, three months to 2026-06-30$719.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
| Operating income | $k | (5,052)Operating income, period not labelled, three months to 2025-03-31−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (884)Operating income, period not labelled, three months to 2025-06-30−$884.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | (1,958)Operating income, Q1 FY2026, three months to 2026-03-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (1,380)Operating income, Q2 FY2026, three months to 2026-06-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
| Net income | $k | (5,052)Net income, period not labelled, three months to 2025-03-31−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (1,008)Net income, period not labelled, three months to 2025-06-30−$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | (2,544)Net income, Q1 FY2026, three months to 2026-03-31−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (1,380)Net income, Q2 FY2026, three months to 2026-06-30−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
| Diluted EPS | $ per share | (0.11)Diluted EPS, period not labelled, three months to 2025-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (0.02)Diluted EPS, period not labelled, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | (0.05)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (0.03)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
| Basic EPS | $ per share | (0.11)Basic EPS, period not labelled, three months to 2025-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (0.02)Basic EPS, period not labelled, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | (0.05)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (0.03)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
Balance sheet
| Line item | Unit | period not labelled2023-12-31 | period not labelled2024-12-31 | period not labelled2025-01-31 | period not labelled2025-03-31 | period not labelled2025-06-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | not reported | 4.6Cash and equivalents, period not labelled, at 2024-12-31$4.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-24, accession 0001213900-26-033064.Report this figure | 0.3Cash and equivalents, period not labelled, at 2025-01-31$250.0k. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | not reported | not reported | 5.1Cash and equivalents, FY2025, at 2025-12-31$5.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 3.1Cash and equivalents, Q1 FY2026, at 2026-03-31$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | 11.5Cash and equivalents, Q2 FY2026, at 2026-06-30$11.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
| Current assets | $m | not reported | 5.0Current assets, period not labelled, at 2024-12-31$5.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-24, accession 0001213900-26-033064.Report this figure | not reported | not reported | not reported | 5.2Current assets, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 3.5Current assets, Q1 FY2026, at 2026-03-31$3.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | 11.8Current assets, Q2 FY2026, at 2026-06-30$11.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
| Total assets | $m | not reported | 5.0Total assets, period not labelled, at 2024-12-31$5.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-24, accession 0001213900-26-033064.Report this figure | not reported | not reported | not reported | 5.2Total assets, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 3.5Total assets, Q1 FY2026, at 2026-03-31$3.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | 11.8Total assets, Q2 FY2026, at 2026-06-30$11.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
| Current liabilities | $m | not reported | 0.3Current liabilities, period not labelled, at 2024-12-31$289.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-24, accession 0001213900-26-033064.Report this figure | not reported | not reported | not reported | 0.6Current liabilities, FY2025, at 2025-12-31$605.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 1.0Current liabilities, Q1 FY2026, at 2026-03-31$1.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | 0.9Current liabilities, Q2 FY2026, at 2026-06-30$873.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
| Total liabilities | $m | not reported | 0.3Total liabilities, period not labelled, at 2024-12-31$289.0k. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-24, accession 0001213900-26-033064.Report this figure | not reported | not reported | not reported | 0.6Total liabilities, FY2025, at 2025-12-31$605.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 1.0Total liabilities, Q1 FY2026, at 2026-03-31$1.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | 0.9Total liabilities, Q2 FY2026, at 2026-06-30$873.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
| Shareholders' equity | $m | 1.3Shareholders' equity, period not labelled, at 2023-12-31$1.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-24, accession 0001213900-26-033064.Report this figure | 4.7Shareholders' equity, period not labelled, at 2024-12-31$4.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | not reported | 4.3Shareholders' equity, period not labelled, at 2025-03-31$4.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 3.2Shareholders' equity, period not labelled, at 2025-06-30$3.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 4.6Shareholders' equity, FY2025, at 2025-12-31$4.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 2.5Shareholders' equity, Q1 FY2026, at 2026-03-31$2.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure | 10.9Shareholders' equity, Q2 FY2026, at 2026-06-30$10.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089118.Report this figure |
Cash flow
| Line item | Unit | period not labelled2025-03-31 | period not labelled2025-06-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|
| Operating cash flow | $k | (709)Operating cash flow, period not labelled, three months to 2025-03-31−$709.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (858)Operating cash flow, period not labelled, three months to 2025-06-30−$858.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001213900-26-089118. Derived: 6-month figure less the 3-month figure.Report this figure | (2,063)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001213900-26-056973.Report this figure | (1,369)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001213900-26-089118. Derived: 6-month figure less the 3-month figure.Report this figure |
Shares
| Line item | Unit | period not labelled2025-03-31 | period not labelled2025-06-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 44.3 | 44.7 | 47.2 | 48.3 |
Shares outstanding: 49.85m at Jul 31, 2026, from the cover of the 10-Q filed Aug 13, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.